ICCM

IceCure Medical Ltd (ICCM) ESG Analysis Analysis (2026)

Invetso Score: 6.3/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

ICCM’s disclosed R&D intensity suggests a modestly innovation-led footprint, but peer-relative environmental benefits remain unclear without emissions, energy, or resource-use disclosures.

Low leverage reduces balance-sheet pressure that can otherwise constrain environmental investment, yet it does not by itself indicate stronger environmental management than peers.

The absence of reported environmental metrics limits evidence of superior climate or operational stewardship, leaving ICCM broadly in line with disclosure-light peers.

No Tier 1 filing evidence provided here indicates material environmental controversies, but the available data are too sparse to support a stronger peer-relative score.

Social

Score:

High stock-based compensation can align employee incentives with long-term value creation, but the elevated ratio also suggests dilution pressure versus more disciplined peers.

R&D spending relative to revenue may support workforce skill development and product quality, yet the data do not show stronger labor or customer outcomes than peers.

The provided metrics contain no direct evidence on safety, turnover, diversity, or community impact, so ICCM’s social positioning remains only moderately assessable.

Compared with peers that disclose broader human-capital metrics, ICCM’s limited social transparency weakens confidence in a stronger relative ESG profile.

Governance

Score:

Very low debt-to-equity indicates conservative capital structure, which can reduce creditor pressure and improve governance flexibility relative to more levered peers.

R&D intensity may reflect board support for long-duration investment, but the absence of filing-based governance disclosures prevents a stronger assessment of oversight quality.

Stock-based compensation at a meaningful revenue share can align management incentives, although it also raises dilution and pay-discipline concerns versus tighter peers.

No controversy or control-failure evidence was provided, but limited disclosure breadth keeps ICCM below stronger-governance peers with clearer accountability frameworks.

Overall Score

Score:

ICCM appears moderately positioned versus peers because conservative leverage and ongoing R&D support governance and social stability, but disclosure gaps limit stronger ESG confidence.

Score Driver: Limited ESG Disclosure Breadth

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on IceCure Medical Ltd. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →